Skip to main content
October 21, 2020
In this video, Joohi Jimenez‑Shahed, MD, explains a 3-year, open-label study which evaluated the long-term efficacy and safety of deutetrabenazine, a treatment for the movement disorder tardive dyskinesia. 
October 06, 2020
In this video, Psych Congress 2020 presenter Timothy Wilens, MD, provides strategies clinicians can use when treating a patient with both attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD).
October 05, 2020
Martha Sajatovic, MD, provides details of a study which found that deutetrabenazine was effective as a treatment for tardive dyskinesia both in patients aged less than 55 years and in patients aged 55 years or older.
October 01, 2020
Deutetrabenazine offers long-term benefit for patients with severe tardive dyskinesia (TD), according to results from a 3-year open-label extension trial presented in a poster at Psych Congress 2020.
October 01, 2020
Adverse events in patients treated with deutetrabenazine were more common during titration than maintenance, a finding that provides “important context for the dosing schedule to providers and patients.”
October 01, 2020
A decrease of 3 points on the Abnormal Involuntary Movement Scale score is the minimal clinically important difference for treatment of tardive dyskinesia with deutetrabenazine, according to a poster presented at Psych Congress 2020. 
September 14, 2020
Physician assistants (PAs) may offer an effective way to ensure patients have access to quality mental health care despite the projected shortage of psychiatrists in the near future, according to a poster presented at Psych Congress 2020.
September 13, 2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD). 
September 13, 2020
Psych Congress 2020 speaker Marc E. Agronin, MD, shares strategies that mental health clinicians can use to adjust psychopharmacologic treatment and dosages for geriatric patients.
September 12, 2020
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the occurrence of cognitive deficits in patients with various psychiatric disorders.
Back to Top